메뉴 건너뛰기




Volumn 152, Issue 5, 2005, Pages 1026-1029

Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: A retrospective study

Author keywords

Docetaxel; HIV; Kaposi's sarcoma

Indexed keywords

DOCETAXEL;

EID: 18944390113     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06452.x     Document Type: Article
Times cited : (12)

References (15)
  • 1
    • 0036233749 scopus 로고    scopus 로고
    • Update on Kaposi's sarcoma and other HHV8 diseases. Part 1. Epidemiology, environmental predispositions, clinical manifestations, and therapy
    • Hengge UR, Ruzicka T, Tyring SK et al. Update on Kaposi's sarcoma and other HHV8 diseases. Part 1. Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2002; 2:281-92.
    • (2002) Lancet Infect Dis , vol.2 , pp. 281-292
    • Hengge, U.R.1    Ruzicka, T.2    Tyring, S.K.3
  • 2
    • 0034035012 scopus 로고    scopus 로고
    • Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients
    • Dupont C, Vasseur E, Beauchet A et al. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. AIDS 2000; 14:987-93.
    • (2000) AIDS , vol.14 , pp. 987-993
    • Dupont, C.1    Vasseur, E.2    Beauchet, A.3
  • 3
    • 0026428123 scopus 로고
    • Studies with RP 56976 (taxotere): A semisynthetic analogue of taxol
    • Ringel I, Horwitz SB. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 1991; 83:288-91.
    • (1991) J Natl Cancer Inst , vol.83 , pp. 288-291
    • Ringel, I.1    Horwitz, S.B.2
  • 4
    • 0037430246 scopus 로고    scopus 로고
    • Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)
    • Grant DS, Williams TL, Zahaczewsky M, Dicker AP. Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere). Int J Cancer 2003; 104:121-9.
    • (2003) Int J Cancer , vol.104 , pp. 121-129
    • Grant, D.S.1    Williams, T.L.2    Zahaczewsky, M.3    Dicker, A.P.4
  • 5
    • 0029061777 scopus 로고
    • Treatment of HIV-associated Kaposi's sarcoma with paclitaxel
    • Saville MW, Lietzau J, Pluda JM et al. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 1995; 346:26-8.
    • (1995) Lancet , vol.346 , pp. 26-28
    • Saville, M.W.1    Lietzau, J.2    Pluda, J.M.3
  • 6
    • 0031911323 scopus 로고    scopus 로고
    • Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma
    • Welles L, Saville MW, Lietzau J et al. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol 1998; 16:1112-21.
    • (1998) J Clin Oncol , vol.16 , pp. 1112-1121
    • Welles, L.1    Saville, M.W.2    Lietzau, J.3
  • 7
    • 0033064114 scopus 로고    scopus 로고
    • Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma
    • Gill PS, Tulpule A, Espina BM et al. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol 1999; 17:1876-83.
    • (1999) J Clin Oncol , vol.17 , pp. 1876-1883
    • Gill, P.S.1    Tulpule, A.2    Espina, B.M.3
  • 8
    • 0036644981 scopus 로고    scopus 로고
    • Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi's sarcoma
    • Tulpule A, Groopman J, Saville MW et al. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi's sarcoma. Cancer 2002; 95:147-54.
    • (2002) Cancer , vol.95 , pp. 147-154
    • Tulpule, A.1    Groopman, J.2    Saville, M.W.3
  • 9
    • 10744225451 scopus 로고    scopus 로고
    • Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: Clinical and angiogenic correlations
    • Stebbing J, Wildfire A, Portsmouth S et al. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. Ann Oncol 2003; 14:1660-6.
    • (2003) Ann Oncol , vol.14 , pp. 1660-1666
    • Stebbing, J.1    Wildfire, A.2    Portsmouth, S.3
  • 10
    • 0024432019 scopus 로고
    • Kaposi's sarcoma in the acquired immune deficiency syndrome: A proposal for uniform evaluation, response, and staging criteria
    • Krown SE, Metroka C, Wernz JC for the AIDS Clinical Trials Group Oncology Committee. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 1989; 7:1201-7.
    • (1989) J Clin Oncol , vol.7 , pp. 1201-1207
    • Krown, S.E.1    Metroka, C.2    Wernz, J.C.3
  • 11
    • 0344412949 scopus 로고    scopus 로고
    • Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma
    • Nasti G, Martellotta F, Berretta M et al. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 2003; 98:2440-6.
    • (2003) Cancer , vol.98 , pp. 2440-2446
    • Nasti, G.1    Martellotta, F.2    Berretta, M.3
  • 12
    • 0031861021 scopus 로고    scopus 로고
    • Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial
    • Northfelt DW, Dezube BJ, Thommes JA et al. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol 1998; 16:2445-51.
    • (1998) J Clin Oncol , vol.16 , pp. 2445-2451
    • Northfelt, D.W.1    Dezube, B.J.2    Thommes, J.A.3
  • 13
    • 0034522138 scopus 로고    scopus 로고
    • Efficacy of docetaxel in disseminated classical Kaposi's sarcoma
    • Stoebner PE, Nocera T, Meynadier J, Meunier L. Efficacy of docetaxel in disseminated classical Kaposi's sarcoma. Br J Dermatol 2000; 143:1357-9.
    • (2000) Br J Dermatol , vol.143 , pp. 1357-1359
    • Stoebner, P.E.1    Nocera, T.2    Meynadier, J.3    Meunier, L.4
  • 14
    • 4243400347 scopus 로고    scopus 로고
    • Activity of Taxotere (docetaxel) as therapy for pretreated HIV-associated Kaposi sarcoma: An ANRS trial
    • ASCO proceedings 47a
    • Boue F, Zaikas G, Lancar R et al. Activity of Taxotere (docetaxel) as therapy for pretreated HIV-associated Kaposi sarcoma: an ANRS trial. J Clin Oncol 1998; 17 [ASCO proceedings 47a].
    • (1998) J Clin Oncol , vol.17
    • Boue, F.1    Zaikas, G.2    Lancar, R.3
  • 15
    • 0042386692 scopus 로고    scopus 로고
    • AIDS-related Kaposi's sarcoma: Evaluation of potential new prognostic factors and assessment of the ALOS clinical trial group staging system in the HAART era-the Italian Cooperative Group on AIDS and Tumors and the Italian cohort of patients naive from antiretrovirals
    • Nasti G, Talamini R, Antinori A et al. AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the ALOS clinical trial group staging system in the HAART era-the Italian Cooperative Group on AIDS and Tumors and the Italian cohort of patients naive from antiretrovirals. J Clin Oncol 2003; 21:2876-82.
    • (2003) J Clin Oncol , vol.21 , pp. 2876-2882
    • Nasti, G.1    Talamini, R.2    Antinori, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.